A detailed history of Ashford Capital Management Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Ashford Capital Management Inc holds 5,390 shares of ABBV stock, worth $946,376. This represents 0.15% of its overall portfolio holdings.

Number of Shares
5,390
Previous 3,980 35.43%
Holding current value
$946,376
Previous $682,000 56.01%
% of portfolio
0.15%
Previous 0.1%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$163.84 - $199.33 $231,014 - $281,055
1,410 Added 35.43%
5,390 $1.06 Million
Q2 2024

Aug 15, 2024

BUY
$154.79 - $180.76 $616,064 - $719,424
3,980 New
3,980 $682,000
Q4 2022

Feb 15, 2023

BUY
$138.31 - $165.87 $179,803 - $215,631
1,300 New
1,300 $210,000
Q2 2022

Aug 15, 2022

SELL
$137.62 - $174.96 $178,906 - $227,448
-1,300 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$131.98 - $163.75 $171,574 - $212,875
1,300 New
1,300 $211,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Ashford Capital Management Inc Portfolio

Follow Ashford Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ashford Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ashford Capital Management Inc with notifications on news.